These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 30111373)

  • 1. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFAIP3 mediates FGFR1 activation-induced breast cancer angiogenesis by promoting VEGFA expression and secretion.
    Gao M; Li X; Yang M; Feng W; Lin Y; He T
    Clin Transl Oncol; 2022 Dec; 24(12):2453-2465. PubMed ID: 36002765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
    Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
    Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
    Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
    J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland.
    Welm BE; Freeman KW; Chen M; Contreras A; Spencer DM; Rosen JM
    J Cell Biol; 2002 May; 157(4):703-14. PubMed ID: 12011115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
    Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
    J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
    Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
    Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
    Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
    J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner.
    Reed JR; Stone MD; Beadnell TC; Ryu Y; Griffin TJ; Schwertfeger KL
    PLoS One; 2012; 7(9):e45877. PubMed ID: 23029290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
    Ory V; Kietzman WB; Boeckelman J; Kallakury BV; Wellstein A; Furth PA; Riegel AT
    Breast Cancer Res Treat; 2018 May; 169(1):47-57. PubMed ID: 29350308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
    Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
    Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
    Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
    J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
    Citron F; Segatto I; Vinciguerra GLR; Musco L; Russo F; Mungo G; D'Andrea S; Mattevi MC; Perin T; Schiappacassi M; Massarut S; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
    Cancer Res; 2020 Mar; 80(5):1064-1077. PubMed ID: 31862778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway.
    Feng W; Gao M; Yang M; Li X; Gan Z; Wu T; Lin Y; He T
    Med Oncol; 2022 Sep; 39(12):230. PubMed ID: 36175778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
    Lee S; Stewart S; Nagtegaal I; Luo J; Wu Y; Colditz G; Medina D; Allred DC
    Cancer Res; 2012 Sep; 72(17):4574-86. PubMed ID: 22751464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
    Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
    Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription Factor FOXQ1 to Promote Breast Cancer Cell Growth.
    Lin Y; Lin F; Zhang Z; Peng L; Yang W; Yang M; Luo B; Wu T; Li D; Li X; Ran B; Anuchapreeda S; Chaiwongsa R; Khamphikham P; Duangmano S; Xu J; He T; Pornprasert S
    Int J Biol Sci; 2023; 19(3):744-759. PubMed ID: 36778115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.